KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $82.7 million.

  • Omega Healthcare Investors' Depreciation & Amortization (CF) rose 526.26% to $82.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $325.2 million, marking a year-over-year increase of 676.16%. This contributed to the annual value of $325.2 million for FY2025, which is 676.16% up from last year.
  • Latest data reveals that Omega Healthcare Investors reported Depreciation & Amortization (CF) of $82.7 million as of Q4 2025, which was up 526.26% from $82.1 million recorded in Q3 2025.
  • In the past 5 years, Omega Healthcare Investors' Depreciation & Amortization (CF) registered a high of $86.1 million during Q3 2021, and its lowest value of $74.2 million during Q2 2024.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $82.1 million (2023), whereas its average is $81.2 million.
  • In the last 5 years, Omega Healthcare Investors' Depreciation & Amortization (CF) tumbled by 963.11% in 2023 and then skyrocketed by 845.3% in 2025.
  • Omega Healthcare Investors' Depreciation & Amortization (CF) (Quarter) stood at $85.3 million in 2021, then decreased by 1.79% to $83.7 million in 2022, then fell by 9.63% to $75.7 million in 2023, then grew by 3.88% to $78.6 million in 2024, then increased by 5.26% to $82.7 million in 2025.
  • Its last three reported values are $82.7 million in Q4 2025, $82.1 million for Q3 2025, and $80.5 million during Q2 2025.